4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-23-006451
Options or other derivatives
- President and CEO acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KOCH KEVIN · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +600,000 | 600,000 | D |
Loading xslF345X05/primarydocument.xml…